/wp-content/uploads/2025/07/Cover_Modi-Sindoor.jpg)
Sun Pharma
Dalal Street’s Suryanamaskar Explained
Shailendra Tyagi
Sun’s bet is that it can fix the factory glitches, get US regulatory clearances, and turn the Sun-Ranbaxy combine into a low-cost generics export powerhouse.
Magazine
Subscribe today and save up to 85% off the cover price
-
-
© 2024 Open Media Network Pvt. Ltd.